Vaxcyte Inc

자세한 내용은 Vaxcyte Inc 회사

Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). VAX-31, the Company’s next generation 31-valent PCV is developed for the prevention of IPD in adults. Its pipeline also includes VAX-A1, VAX-PG, and VAX-GI. VAX-A1, a novel conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus (Group A Strep). VAX-PG, a novel protein vaccine candidate targeting pathogen responsible for periodontitis, a chronic oral inflammatory disease. VAX-GI, a novel preclinical vaccine candidate being developed as a preventative treatment for dysentery and shigellosis. Its technology platform includes advanced chemistry and the XpressCF cell-free protein synthesis platform.

회사 정보

종목 코드 PCVX

회사 이름Vaxcyte Inc

상장일Jun 12, 2020

CEOMr. Grant E. Pickering

직원 수414

유형Ordinary Share

회계 연도 종료Jun 12

주소825 Industrial Road, Ste. 300

도시SAN CARLOS

증권 거래소NASDAQ Global Select Consolidated

국가United States of America

우편 번호94070

전화16508370111

웹사이트https://vaxcyte.com/

종목 코드 PCVX

상장일Jun 12, 2020

CEOMr. Grant E. Pickering

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Grant E. Pickering

Chief Executive Officer, Co-Founder, Director

676.65K

+3.13%

Mr. Andrew L. Guggenhime

President, Chief Financial Officer

83.56K

+6.06%

Mr. James (Jim) Wassil

Executive Vice President, Chief Operating Officer

34.31K

+21.13%

Mr. Mikhail Eydelman, J.D.

Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary

12.60K

-28.82%

Dr. Carlos V. Paya, M.D., Ph.D.

Independent Chairman of the Board

8.67K

+54.06%

Ms. Teri Loxam

Independent Director

8.67K

+54.06%

Mr. Jacks Lee

Independent Director

3.04K

--

Mr. John P. Furey

Independent Director

3.04K

--

Dr. Olivier Brandicourt

Independent Director

1.15K

--

Dr. Heath Lukatch, Ph.D.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Grant E. Pickering

Chief Executive Officer, Co-Founder, Director

676.65K

+3.13%

Mr. Andrew L. Guggenhime

President, Chief Financial Officer

83.56K

+6.06%

Mr. James (Jim) Wassil

Executive Vice President, Chief Operating Officer

34.31K

+21.13%

Mr. Mikhail Eydelman, J.D.

Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary

12.60K

-28.82%

Dr. Carlos V. Paya, M.D., Ph.D.

Independent Chairman of the Board

8.67K

+54.06%

Ms. Teri Loxam

Independent Director

8.67K

+54.06%

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sat, Aug 2

주주

주주 유형

주주

비율

Janus Henderson Investors

11.27%

RA Capital Management, LP

9.45%

The Vanguard Group, Inc.

9.32%

Fidelity Management & Research Company LLC

8.31%

BlackRock Institutional Trust Company, N.A.

7.08%

Other

54.57%

주주

비율

Janus Henderson Investors

11.27%

RA Capital Management, LP

9.45%

The Vanguard Group, Inc.

9.32%

Fidelity Management & Research Company LLC

8.31%

BlackRock Institutional Trust Company, N.A.

7.08%

Other

54.57%

주주 유형

주주

비율

Investment Advisor

47.62%

Investment Advisor/Hedge Fund

40.88%

Hedge Fund

12.35%

Venture Capital

10.72%

Research Firm

1.95%

Private Equity

0.97%

Sovereign Wealth Fund

0.85%

Bank and Trust

0.73%

Individual Investor

0.70%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

652

151.34M

117.31%

-374.47K

2025Q1

669

149.26M

115.73%

-5.52M

2024Q4

629

143.44M

111.44%

-3.61M

2024Q3

579

138.80M

114.99%

+5.28M

2024Q2

508

125.57M

113.86%

-5.08M

2024Q1

487

122.06M

113.01%

+8.05M

2023Q4

444

106.09M

111.72%

-6.02M

2023Q3

417

110.70M

121.97%

-7.51M

2023Q2

397

109.13M

122.07%

+11.09M

2023Q1

366

92.70M

119.26%

-1.36M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Janus Henderson Investors

14.54M

11.27%

+2.77M

+23.58%

Apr 30, 2025

RA Capital Management, LP

12.19M

9.45%

+3.50M

+40.28%

Mar 31, 2025

The Vanguard Group, Inc.

12.02M

9.32%

+82.12K

+0.69%

Mar 31, 2025

Fidelity Management & Research Company LLC

10.73M

8.31%

-632.25K

-5.57%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

9.13M

7.08%

-112.81K

-1.22%

Mar 31, 2025

Wellington Management Company, LLP

6.42M

4.97%

+1.97M

+44.39%

Mar 31, 2025

Capital Research Global Investors

6.11M

4.74%

-100.42K

-1.62%

Mar 31, 2025

State Street Global Advisors (US)

4.41M

3.42%

-131.72K

-2.90%

Mar 31, 2025

T. Rowe Price Associates, Inc.

3.44M

2.66%

-429.53K

-11.11%

Mar 31, 2025

Kynam Capital Management LP

3.20M

2.48%

+863.20K

+36.94%

Mar 31, 2025

32.960USD

Vaxcyte Inc

32.960

개요

회사

금융